Last reviewed · How we verify
Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab is a Small molecule drug developed by ARCAGY/ GINECO GROUP. It is currently in Phase 2 development.
At a glance
| Generic name | Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab |
|---|---|
| Sponsor | ARCAGY/ GINECO GROUP |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) (PHASE1)
- PEMBRO With Chemo in Neo Adj Treatment of Ovarian Cancer . (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab CI brief — competitive landscape report
- Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab updates RSS · CI watch RSS
- ARCAGY/ GINECO GROUP portfolio CI
Frequently asked questions about Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab
What is Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab?
Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab is a Small molecule drug developed by ARCAGY/ GINECO GROUP.
Who makes Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab?
Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab is developed by ARCAGY/ GINECO GROUP (see full ARCAGY/ GINECO GROUP pipeline at /company/arcagy-gineco-group).
What development phase is Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab in?
Pembrolizumab Injectable Product - Chemotherapy - Bevacizumab is in Phase 2.